Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Merck
Daiichi Sankyo
QuintilesIMS
Federal Trade Commission

Generated: May 20, 2019

DrugPatentWatch Database Preview

BRISDELLE Drug Profile

« Back to Dashboard

When do Brisdelle patents expire, and when can generic versions of Brisdelle launch?

Brisdelle is a drug marketed by Sebela Ireland Ltd and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has seventy-eight patent family members in thirty-five countries.

The generic ingredient in BRISDELLE is paroxetine mesylate. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.

Drug patent expirations by year for BRISDELLE
Pharmacology for BRISDELLE
Synonyms for BRISDELLE
(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine methanesulfonate
217797-14-3
AKOS027321054
Brisdelle (TN)
CHEMBL1200609
D05375
LDMP
M711N184JE
Paroxetine Mesilate
Paroxetine Mesylate
Paroxetine mesylate (USAN)
Paroxetine Mesylate [USAN]
Paroxetine methanesulphonate
Pexeva
Pexeva (TN)
POT.mes
SCHEMBL143905
SHIJTGJXUHTGGZ-RVXRQPKJSA-N
UNII-M711N184JE

US Patents and Regulatory Information for BRISDELLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd BRISDELLE paroxetine mesylate CAPSULE;ORAL 204516-001 Jun 28, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Sebela Ireland Ltd BRISDELLE paroxetine mesylate CAPSULE;ORAL 204516-001 Jun 28, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Sebela Ireland Ltd BRISDELLE paroxetine mesylate CAPSULE;ORAL 204516-001 Jun 28, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BRISDELLE
Drugname Dosage Strength RLD Date
➤ Subscribe Capsules 7.5 mg ➤ Subscribe ➤ Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Daiichi Sankyo
Citi
Colorcon
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.